AC Immune SA
ACIU- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001651625
No open-market purchases or sales by AC Immune SA insiders were filed in the last 90 days; 43 institutions reported holding it in 13F filings for Q2 2026, worth $58.2M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding AC Immune SA changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 36 | 1 | 35 | 0 |
| Shares | 14.3M | 24.7K | 13.8M | −465.7K (−3.3%) |
| Value | $57.2M | $99.0K | $49.8M | −$7.25M (−12.7%) |
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (5)
Institutions that held AC Immune SA at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BNP Paribas Arbitrage, SA | 2,869 | $10.4K | 0.00% |
| Edmond de Rothschild Holding S.A. | 1,000 | $4.00K | 0.00% |
| Venture Visionary Partners LLC | 410 | $1.48K | 0.00% |
| Simplex Trading, LLC | 310 | $1.00K | 0.00% |
| Glassman Wealth Services | 26 | $0 | 0.00% |
Sold out (5)
Institutions that held AC Immune SA at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| EcoR1 Capital, LLC | 485,005 | $1.94M |
| Alpine Woods Capital Investors, LLC | 50,000 | $200.0K |
| Virtus ETF Advisers LLC | 31,014 | $124.0K |
| Two Sigma Advisers, LP | 23,644 | $95.0K |
| HRT Financial LP | 10,520 | $42.0K |
Not filed for Q2 2022 yet (1)
Institutions that held AC Immune SA at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Susquehanna Fundamental Investments, LLC | 24,717 | $99.0K |